P Greminger

1.7k total citations
91 papers, 1.1k citations indexed

About

P Greminger is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P Greminger has authored 91 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P Greminger's work include Renal and Vascular Pathologies (15 papers), Blood Pressure and Hypertension Studies (15 papers) and Hormonal Regulation and Hypertension (12 papers). P Greminger is often cited by papers focused on Renal and Vascular Pathologies (15 papers), Blood Pressure and Hypertension Studies (15 papers) and Hormonal Regulation and Hypertension (12 papers). P Greminger collaborates with scholars based in Switzerland, Germany and Luxembourg. P Greminger's co-authors include W. Vetter, W Siegenthaler, H. Vetter, Thomas F. Lüscher, U. Kuhlmann, H Groth, Ernst Schneider, W Vetter, Hugo Kupferschmidt and Rudolf Speich and has published in prestigious journals such as Hepatology, The American Journal of Medicine and The Journal of Urology.

In The Last Decade

P Greminger

81 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Greminger Switzerland 18 347 321 282 196 73 91 1.1k
M Pfeffer United States 16 142 0.4× 325 1.0× 229 0.8× 90 0.5× 70 1.0× 28 1.3k
Assad Movahed United States 19 236 0.7× 548 1.7× 212 0.8× 74 0.4× 85 1.2× 80 1.0k
Farahnak Assadi United States 22 256 0.7× 251 0.8× 165 0.6× 117 0.6× 172 2.4× 125 1.4k
Edward T. Zawada United States 18 172 0.5× 197 0.6× 154 0.5× 159 0.8× 104 1.4× 88 1.1k
C Caulin France 18 77 0.2× 388 1.2× 185 0.7× 60 0.3× 79 1.1× 73 1.5k
Jørgen Fischer Hansen Denmark 25 216 0.6× 959 3.0× 389 1.4× 81 0.4× 53 0.7× 71 1.6k
Peter Stewart United Kingdom 23 253 0.7× 253 0.8× 199 0.7× 152 0.8× 206 2.8× 75 1.5k
James R. Oster United States 25 794 2.3× 337 1.0× 219 0.8× 254 1.3× 134 1.8× 86 1.7k
W. A. Mahon Canada 24 198 0.6× 161 0.5× 180 0.6× 87 0.4× 69 0.9× 47 1.1k
N Pozet France 20 199 0.6× 275 0.9× 176 0.6× 93 0.5× 52 0.7× 86 1.1k

Countries citing papers authored by P Greminger

Since Specialization
Citations

This map shows the geographic impact of P Greminger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Greminger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Greminger more than expected).

Fields of papers citing papers by P Greminger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Greminger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Greminger. The network helps show where P Greminger may publish in the future.

Co-authorship network of co-authors of P Greminger

This figure shows the co-authorship network connecting the top 25 collaborators of P Greminger. A scholar is included among the top collaborators of P Greminger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Greminger. P Greminger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greminger, P, et al.. (2012). Eitrige Lymphadenitis nach Abszesstonsillektomie bei Immunsuppression. HNO. 60(7). 622–625.
2.
Greminger, P, et al.. (2009). Secondary Adrenal Insufficiency due to Opiate Therapy – Another Differential Diagnosis Worth Consideration. Experimental and Clinical Endocrinology & Diabetes. 117(10). 649–651. 23 indexed citations
3.
Flepp, Markus, K Rhyner, R Lüthy, et al.. (2008). Mykobakteriosen bei Patienten mit HIV-Infektion. DMW - Deutsche Medizinische Wochenschrift. 113(18). 711–718.
4.
Grüne, S., et al.. (2008). Auftreten eines Sweet-Syndroms beim Übergang von einem myelodysplastischen Syndrom in eine Erythroleukämie. DMW - Deutsche Medizinische Wochenschrift. 121(30). 939–942. 1 indexed citations
5.
Schwitter, Juerg, et al.. (2008). Hirnabszeß als Komplikation des Morbus Osler mit Lungenbeteiligung. DMW - Deutsche Medizinische Wochenschrift. 116(42). 1591–1596.
6.
Liechti, Matthias E., et al.. (2005). Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Drug and Alcohol Dependence. 81(3). 323–326. 77 indexed citations
7.
Burnier, Michel, Bernhard Hess, P Greminger, & Bernard Waeber. (2005). Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey. BMC Cardiovascular Disorders. 5(1). 13–13. 23 indexed citations
8.
Greminger, P, et al.. (1997). [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)].. PubMed. 86(45). 1779–84. 1 indexed citations
9.
Greminger, P, et al.. (1997). Systemic vasculitis associated with seronegative spondylarthropathy (Reiter's syndrome). Clinical Rheumatology. 16(6). 610–613. 2 indexed citations
10.
Greminger, P, et al.. (1995). Combined Treatment with Captopril, Hydrochlorothiazide and Pravastatin in Dyslipidemic Hypertensive Patients. Blood Pressure. 4(6). 358–362. 3 indexed citations
11.
Moradpour, Darius, J Altorfer, Renata Flury, et al.. (1994). Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology. 20(6). 1437–1441. 83 indexed citations
12.
Mengden, Thomas, et al.. (1992). Urinary free cortisol versus 17-hydroxycorticosteroids a comparative study of their diagnostic value in Cushing's syndrome. Journal of Molecular Medicine. 70(7). 545–8. 54 indexed citations
13.
Maire, R, J Altorfer, R Ammann, et al.. (1992). [How does oligo- en asymptomatic non-tropical sprue present itself?].. PubMed. 122(51-52). 1957–60. 2 indexed citations
14.
Greminger, P, Hess Om, L. K. von Segesser, et al.. (1991). Bronchial neuroendocrine (carcinoid) tumor causing unilateral left-sided carcinoid heart disease. Journal of Molecular Medicine. 69(3). 128–133. 9 indexed citations
15.
Greminger, P, Ernst Schneider, U. Kuhlmann, et al.. (1989). Cure and Improvement of Renovascular Hypertension after Percutaneous Transluminal Angioplasty of Renal Artery Stenosis. ˜The œNephron journals/Nephron journals. 51(3). 362–366. 20 indexed citations
16.
Lüscher, Thomas F., P Greminger, U. Kuhlmann, et al.. (1986). Renal Venous Renin Determinations in Renovascular Hypertension. ˜The œNephron journals/Nephron journals. 44(1). 17–24. 20 indexed citations
17.
Lüscher, Thomas F., H. M. Keller, H. Imhof, et al.. (1986). Fibromuscular Hyperplasia: Extension of the Disease and Therapeutic Outcome. ˜The œNephron journals/Nephron journals. 44(1). 109–114. 86 indexed citations
18.
Stimpel, M., et al.. (1985). The Spectrum of Renovascular Hypertension. Cardiology. 72(1). 1–9. 9 indexed citations
19.
Lüscher, T, H. Vetter, W. Tenschert, et al.. (1983). Problem cases in renovascular hypertension.. PubMed. 19(6). 299–308. 7 indexed citations
20.
Greminger, P, W. Vetter, Katharina Zimmermann, R. Beckerhoff, & W Siegenthaler. (1977). [Primary and secondary hypertension in polyclinical patients].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 107(17). 605–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Pfeffer Breakdown of academic impact, for papers by Assad Movahed Breakdown of academic impact, for papers by Farahnak Assadi Breakdown of academic impact, for papers by Edward T. Zawada Breakdown of academic impact, for papers by C Caulin Breakdown of academic impact, for papers by Jørgen Fischer Hansen Breakdown of academic impact, for papers by Peter Stewart Breakdown of academic impact, for papers by James R. Oster Breakdown of academic impact, for papers by W. A. Mahon Breakdown of academic impact, for papers by N Pozet
Rankless by CCL
2026